Literature DB >> 20843820

Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivors.

Christopher I Li1, Nobuo Nishi, Jean A McDougall, Erin O Semmens, Hiromi Sugiyama, Midori Soda, Ritsu Sakata, Mikiko Hayashi, Fumiyoshi Kasagi, Akihiko Suyama, Kiyohiko Mabuchi, Scott Davis, Kazunori Kodama, Kenneth J Kopecky.   

Abstract

Radiation exposure is related to risk of numerous types of cancer, but relatively little is known about its effect on risk of multiple primary cancers. Using follow-up data through 2002 from 77,752 Japanese atomic bomb survivors, we identified 14,048 participants diagnosed with a first primary cancer, of whom 1,088 were diagnosed with a second primary cancer. Relationships between radiation exposure and risks of first and second primary cancers were quantified using Poisson regression. There was a similar linear dose-response relationship between radiation exposure and risks of both first and second primary solid tumors [excess relative risk (ERR)/Gy = 0.65; 95% confidence interval (CI), 0.57-0.74 and ERR/Gy = 0.56; 95% CI, 0.33-0.80, respectively] and risk of both first and second primary leukemias (ERR/Gy = 2.65; 95% CI, 1.78-3.78 and ERR/Gy = 3.65; 95% CI, 0.96-10.70, respectively). Background incidence rates were higher for second solid cancers, compared with first solid cancers, until about age 70 years for men and 80 years for women (P < 0.0001), but radiation-related ERRs did not differ between first and second primary solid cancers (P = 0.70). Radiation dose was most strongly related to risk of solid tumors that are radiation-sensitive including second primary lung, colon, female breast, thyroid, and bladder cancers. Radiation exposure confers equally high relative risks of second primary cancers as first primary cancers. Radiation is a potent carcinogen and those with substantial exposures who are diagnosed with a first primary cancer should be carefully screened for second primary cancers, particularly for cancers that are radiation-sensitive. ©2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20843820      PMCID: PMC2941904          DOI: 10.1158/0008-5472.CAN-10-0276

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors.

Authors:  Deirdre A Hill; Ethel Gilbert; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Tom Wiklund; Charles F Lynch; Mars Van't Veer; Hans Storm; Eero Pukkala; Marilyn Stovall; Rochelle E Curtis; James M Allan; John D Boice; Lois B Travis
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

2.  Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma.

Authors:  A I Neugut; H Ahsan; E Robinson; R D Ennis
Journal:  Cancer       Date:  1997-04-15       Impact factor: 6.860

3.  Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer.

Authors:  Lydia B Zablotska; Amitabh Chak; Ananya Das; Alfred I Neugut
Journal:  Am J Epidemiol       Date:  2005-02-15       Impact factor: 4.897

4.  Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.

Authors:  Carole Rubino; Akthar Shamsaldin; Monique G Lê; Martine Labbé; Jean-Marc Guinebretière; Jean Chavaudra; Florent de Vathaire
Journal:  Breast Cancer Res Treat       Date:  2005-02       Impact factor: 4.872

5.  Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates.

Authors:  Dale L Preston; Donald A Pierce; Yukiko Shimizu; Harry M Cullings; Shoichiro Fujita; Sachiyo Funamoto; Kazunori Kodama
Journal:  Radiat Res       Date:  2004-10       Impact factor: 2.841

6.  Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer.

Authors:  Christopher I Li; Janet R Daling; Peggy L Porter; Mei-Tzu C Tang; Kathleen E Malone
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

7.  Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.

Authors:  Lois B Travis; Deirdre A Hill; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Tom Wiklund; Charles F Lynch; Mars B Van't Veer; Ingrid Glimelius; Hans Storm; Eero Pukkala; Marilyn Stovall; Rochelle Curtis; John D Boice; Ethel Gilbert
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

8.  Solid cancer incidence in atomic bomb survivors: 1958-1998.

Authors:  D L Preston; E Ron; S Tokuoka; S Funamoto; N Nishi; M Soda; K Mabuchi; K Kodama
Journal:  Radiat Res       Date:  2007-07       Impact factor: 2.841

9.  Radiation dose, chemotherapy and risk of lung cancer after breast cancer treatment.

Authors:  Carole Rubino; Florent de Vathaire; Ibrahima Diallo; Akthar Shamsaldin; Emmanuel Grimaud; Martine Labbe; Genevieve Contesso; Monique Le
Journal:  Breast Cancer Res Treat       Date:  2002-09       Impact factor: 4.872

Review 10.  Second primary breast cancer after Hodgkin's disease.

Authors:  A Horwich; A J Swerdlow
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

View more
  15 in total

Review 1.  Cancer risk related to gastrointestinal diagnostic radiation exposure.

Authors:  Mimi L Chang; Jason K Hou
Journal:  Curr Gastroenterol Rep       Date:  2011-10

2.  Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study.

Authors:  Sarah E Daugherty; James V Lacey; Ruth M Pfeiffer; Yikyung Park; Robert N Hoover; Debra T Silverman
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

3.  Among Individuals Irradiated for Benign Conditions in Childhood, Developing Thyroid Cancer Does Not Affect All-Cause Survival.

Authors:  Leonid Vydro; Cari M Kitahara; Jay H Lubin; Arthur B Schneider; Dan V Mihailescu
Journal:  Thyroid       Date:  2020-01-16       Impact factor: 6.568

Review 4.  Bladder cancer after radiotherapy for prostate cancer.

Authors:  Francesca Suriano; Emanuela Altobelli; Federico Sergi; Maurizio Buscarini
Journal:  Rev Urol       Date:  2013

5.  Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Renée L Mulder; Leontien C M Kremer; Melissa M Hudson; Smita Bhatia; Wendy Landier; Gill Levitt; Louis S Constine; W Hamish Wallace; Flora E van Leeuwen; Cécile M Ronckers; Tara O Henderson; Mary Dwyer; Roderick Skinner; Kevin C Oeffinger
Journal:  Lancet Oncol       Date:  2013-12       Impact factor: 41.316

Review 6.  Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique.

Authors:  Louise Murray; Ann Henry; Peter Hoskin; Frank-Andre Siebert; Jack Venselaar
Journal:  Radiother Oncol       Date:  2014-01-30       Impact factor: 6.280

7.  Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis.

Authors:  Nina-Sophie Hegemann; Anne Schlesinger-Raab; Ute Ganswindt; Claudia Hörl; Stephanie E Combs; Dieter Hölzel; Jürgen E Gschwend; Christian Stief; Claus Belka; Jutta Engel
Journal:  Radiat Oncol       Date:  2017-01-03       Impact factor: 3.481

8.  Dose-dependent effects of gamma radiation on the early zebrafish development and gene expression.

Authors:  Selma Hurem; Leonardo Martín Martín; Dag Anders Brede; Eystein Skjerve; Rasoul Nourizadeh-Lillabadi; Ole Christian Lind; Terje Christensen; Vidar Berg; Hans-Christian Teien; Brit Salbu; Deborah Helen Oughton; Peter Aleström; Jan Ludvig Lyche
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

9.  Epidemiological research on radiation-induced cancer in atomic bomb survivors.

Authors:  Kotaro Ozasa
Journal:  J Radiat Res       Date:  2016-03-13       Impact factor: 2.724

10.  The Prognostic Value of Previous Irradiation on Survival of Bladder Cancer Patients.

Authors:  Kevin Krughoff; Tamara P Lhungay; Zuhair Barqawi; Colin O'Donnell; Ashish Kamat; Shandra Wilson
Journal:  Bladder Cancer       Date:  2015-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.